Slit-2 Induces a Tumor-suppressive Effect by Regulating β-Catenin in Breast Cancer Cells*

SLIT-2 is considered as a candidate tumor suppressor gene, because it is frequently inactivated in various cancers due to hypermethylation of its promoter region and allelic loss. However, the exact mechanism of its tumor-suppressive effect has not been elucidated. Here, we observed that Slit-2-overexpressing breast cancer cells exhibited decreased proliferation and migration capabilities compared with control cells under in vitro conditions. These results were confirmed in vivo in mouse model systems. Mice injected with MCF-7/Slit-2 cells showed a 60–70% reduction in tumor size compared with mice injected with MCF-7/VC cells both in the absence and presence of estrogen. Upon further elucidation, we observed that Slit-2 mediates the tumor-suppressive effect via a coordinated regulation of the β-catenin and PI3K signaling pathways and by enhancing β-catenin/E-cadherin-mediated cell-cell adhesion. Our study for the first time reveals that Slit-2-overexpressing breast cancer cells exhibit tumor suppressor capabilities through the novel mechanism of β-catenin modulation.

[1]  J. Lilien,et al.  Cables links Robo-bound Abl kinase to N-cadherin-bound β-catenin to mediate Slit-induced modulation of adhesion and transcription , 2007, Nature Cell Biology.

[2]  Gordon B. Mills,et al.  Phosphorylation of β-Catenin by AKT Promotes β-Catenin Transcriptional Activity* , 2007, Journal of Biological Chemistry.

[3]  A. Zlotnik.  Chemokines and cancer , 2006, International journal of cancer.

[4]  Y. Rao,et al.  Inhibition of medulloblastoma cell invasion by Slit , 2006, Oncogene.

[5]  Nadine H. Soplop,et al.  Lateral positioning at the dorsal midline: Slit and Roundabout receptors guide Drosophila heart cell migration , 2006, Proceedings of the National Academy of Sciences.

[6]  C. Loddenkemper,et al.  Robo1/Robo4: differential expression of angiogenic markers in colorectal cancer. , 2006, Oncology reports.

[7]  M. Ghazizadeh,et al.  Potential role of the Slit/Robo signal pathway in angiogenesis , 2006, Vascular medicine.

[8]  M. Katoh,et al.  Comparative genomics on SLIT1, SLIT2, and SLIT3 orthologs. , 2005, Oncology reports.

[9]  T. Rowlands,et al.  Cadherins and catenins in breast cancer. , 2005, Current opinion in cell biology.

[10]  V. Sukhatme,et al.  Magic roundabout, a tumor endothelial marker: expression and signaling. , 2005, Biochemical and biophysical research communications.

[11]  P. V. Van Veldhuizen,et al.  Stimulation of MCF-7 tumor progression in athymic nude mice by 17beta-estradiol induces WISP-2/CCN5 expression in xenografts: a novel signaling molecule in hormonal carcinogenesis. , 2005, Oncology reports.

[12]  E. Hohenester,et al.  Binding site for Robo receptors revealed by dissection of the leucine‐rich repeat region of Slit , 2004, The EMBO journal.

[13]  I. Bièche,et al.  Epigenetic inactivation of SLIT3 and SLIT1 genes in human cancers , 2004, British Journal of Cancer.

[14]  M. Tessier-Lavigne,et al.  SLIT2-mediated ROBO2 signaling restricts kidney induction to a single site. , 2004, Developmental cell.

[15]  Y. Rao,et al.  Slit Protein-mediated Inhibition of CXCR4-induced Chemotactic and Chemoinvasive Signaling Pathways in Breast Cancer Cells* , 2004, Journal of Biological Chemistry.

[16]  M. Yao,et al.  SLIT2 promoter methylation analysis in neuroblastoma, Wilms' tumour and renal cell carcinoma , 2004, British Journal of Cancer.

[17]  C. Elmets,et al.  Neuronal Repellent Slit2 Inhibits Dendritic Cell Migration and the Development of Immune Responses1 , 2003, The Journal of Immunology.

[18]  R. O. Stuart,et al.  Changes in gene expression patterns in the ureteric bud and metanephric mesenchyme in models of kidney development. , 2003, Kidney international.

[19]  K. Hunt,et al.  MDA-7 negatively regulates the beta-catenin and PI3K signaling pathways in breast and lung tumor cells. , 2003, Molecular therapy : the journal of the American Society of Gene Therapy.

[20]  Charis Eng,et al.  Frequent epigenetic inactivation of the SLIT2 gene in gliomas , 2003, Oncogene.

[21]  J. Foidart,et al.  Transactivation of Vimentin by β-Catenin in Human Breast Cancer Cells , 2003 .

[22]  T. Rowlands,et al.  β-Catenin and Tcfs in Mammary Development and Cancer , 2003, Journal of Mammary Gland Biology and Neoplasia.

[23]  D. Morton,et al.  SLIT2 axon guidance molecule is frequently inactivated in colorectal cancer and suppresses growth of colorectal carcinoma cells. , 2003, Cancer research.

[24]  Jane Y. Wu,et al.  Slit and robo: expression patterns in lung development. , 2003, Gene expression patterns : GEP.

[25]  J. Minna,et al.  SLIT2, a human homologue of the Drosophila Slit2 gene, has tumor suppressor activity and is frequently inactivated in lung and breast cancers. , 2002, Cancer research.

[26]  Y. Rao,et al.  Slit proteins: molecular guidance cues for cells ranging from neurons to leukocytes. , 2002, Current opinion in genetics & development.

[27]  J. Lilien,et al.  Activation of the repulsive receptor Roundabout inhibits N-cadherin-mediated cell adhesion , 2002, Nature Cell Biology.

[28]  Matthias Mann,et al.  Axin-mediated CKI phosphorylation of beta-catenin at Ser 45: a molecular switch for the Wnt pathway. , 2002, Genes & development.

[29]  T. Rabbitts,et al.  Inadequate lung development and bronchial hyperplasia in mice with a targeted deletion in the Dutt1/Robo1 gene , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[30]  A. Nagafuchi.  Molecular architecture of adherens junctions. , 2001, Current opinion in cell biology.

[31]  M. Mareel,et al.  Defective E-cadherin/catenin complexes in human cancer , 2001, Virchows Archiv.

[32]  C. Weston,et al.  Signal transduction: signaling specificity- a complex affair. , 2001, Science.

[33]  J. Jacobs,et al.  Repellent Signaling by Slit Requires the Leucine-Rich Repeats , 2001, The Journal of Neuroscience.

[34]  Julie H. Simpson,et al.  Switching Repulsion to Attraction: Changing Responses to Slit During Transition in Mesoderm Migration , 2001, Science.

[35]  Y. Rao,et al.  The N-terminal Leucine-Rich Regions in Slit Are Sufficient To Repel Olfactory Bulb Axons and Subventricular Zone Neurons , 2001, The Journal of Neuroscience.

[36]  E. Fuchs,et al.  Actin dynamics and cell-cell adhesion in epithelia. , 2001, Current opinion in cell biology.

[37]  Julie H. Simpson,et al.  Short-Range and Long-Range Guidance by Slit and Its Robo Receptors Robo and Robo2 Play Distinct Roles in Midline Guidance , 2000, Neuron.

[38]  B. Dickson,et al.  Crossing the Midline Roles and Regulation of Robo Receptors , 2000, Neuron.

[39]  G. Mills,et al.  Phosphorylation and inactivation of glycogen synthase kinase 3 by protein kinase A. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[40]  M. Duffy,et al.  Metalloproteinases: role in breast carcinogenesis, invasion and metastasis , 2000, Breast Cancer Research.

[41]  Toshiya Yamada,et al.  Expression of the vertebrate Slit Gene family and their putative receptors, the Robo genes, in the developing murine kidney , 2000, Mechanisms of Development.

[42]  E. Fearon.  BRCA1 and E-cadherin promoter hypermethylation and gene inactivation in cancer-association or mechanism? , 2000, Journal of the National Cancer Institute.

[43]  G. Chenevix-Trench,et al.  Assignment1 of the human slit homologue SLIT2 to human chromosome band 4p15.2 , 1999, Cytogenetic and Genome Research.

[44]  Thomas Kirchner,et al.  β-Catenin Regulates the Expression of the Matrix Metalloproteinase-7 in Human Colorectal Cancer , 1999 .

[45]  Y. Rao,et al.  The mouse SLIT family: secreted ligands for ROBO expressed in patterns that suggest a role in morphogenesis and axon guidance. , 1999, Developmental biology.

[46]  C. Goodman,et al.  Chimeric Axon Guidance Receptors The Cytoplasmic Domains of Slit and Netrin Receptors Specify Attraction versus Repulsion , 1999, Cell.

[47]  Paul Polakis,et al.  The metalloproteinase matrilysin is a target of β-catenin transactivation in intestinal tumors , 1999, Oncogene.

[48]  Frank McCormick,et al.  β-Catenin regulates expression of cyclin D1 in colon carcinoma cells , 1999, Nature.

[49]  C. Goodman,et al.  Biochemical Purification of a Mammalian Slit Protein as a Positive Regulator of Sensory Axon Elongation and Branching , 1999, Cell.

[50]  C. Goodman,et al.  Slit Is the Midline Repellent for the Robo Receptor in Drosophila , 1999, Cell.

[51]  Y. Rao,et al.  Vertebrate Slit, a Secreted Ligand for the Transmembrane Protein Roundabout, Is a Repellent for Olfactory Bulb Axons , 1999, Cell.

[52]  C. Goodman,et al.  Slit Proteins Bind Robo Receptors and Have an Evolutionarily Conserved Role in Repulsive Axon Guidance , 1999, Cell.

[53]  H Clevers,et al.  Expression of CD44 in Apc and Tcf mutant mice implies regulation by the WNT pathway. , 1999, The American journal of pathology.

[54]  J. Bergh,et al.  Homozygous deletions at 3p12 in breast and lung cancer , 1998, Oncogene.

[55]  A. Sparks,et al.  Identification of c-MYC as a target of the APC pathway. , 1998, Science.

[56]  A. Børresen-Dale,et al.  E‐cadherin and α‐, β‐, and γ‐catenin protein expression in relation to metastasis in human breast carcinoma , 1998 .

[57]  Paul Polakis,et al.  Binding of GSK3β to the APC-β-Catenin Complex and Regulation of Complex Assembly , 1996, Science.

[58]  P. Polakis,et al.  Wnt-1 regulates free pools of catenins and stabilizes APC-catenin complexes , 1996, Molecular and cellular biology.

[59]  P. Cohen,et al.  Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B , 1995, Nature.

[60]  M. Takeichi,et al.  Cadherin cell adhesion receptors as a morphogenetic regulator. , 1991, Science.

[61]  J. Foidart,et al.  Transactivation of MCP‐1/CCL2 by β‐catenin/TCF‐4 in human breast cancer cells , 2006, International journal of cancer.

[62]  P. Watson,et al.  Influence of c-myc on the progression of human breast cancer. , 1996, Current topics in microbiology and immunology.